ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 32 filers reported holding ONCOLYTICS BIOTECH INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $458 | -16.1% | 210 | 0.0% | 0.00% | – |
| Q2 2023 | $546 | +116.7% | 210 | 0.0% | 0.00% | – |
| Q1 2023 | $252 | -26.3% | 210 | 0.0% | 0.00% | – |
| Q4 2022 | $342 | – | 210 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 210 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 210 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 210 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 210 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 210 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | – | 210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 25,000 | $41 | 0.05% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 183,783 | $299,566 | 0.03% |
| BRAVE ASSET MANAGEMENT INC | 20,000 | $32,772 | 0.01% |
| Newman Dignan & Sheerar, Inc. | 18,915 | $30,831 | 0.01% |
| Virtu Financial LLC | 24,953 | $41 | 0.01% |
| Long Focus Capital Management, LLC | 40,000 | $65,200 | 0.00% |
| Cedar Mountain Advisors, LLC | 5,651 | $9,211 | 0.00% |
| Banque Cantonale Vaudoise | 11,900 | $19 | 0.00% |
| SITTNER & NELSON, LLC | 1,000 | $1,639 | 0.00% |
| OSAIC HOLDINGS, INC. | 8,332 | $13,000 | 0.00% |